Kurser indlæses...

Prognose

Vi har ingen analytikerdata for denne virksomhed.

Nyheder Til nyhedsfeedet

Vext closes Ohio branch after probe into health incidents

Vext voluntarily closes its dispensary "Herbal Wellness Center" in Jackson, Ohio, at the request of the Ohio Division of Cannabis Control (DCC) amid investigations into two serious health incidents. The company reports no conclusive evidence that Vext products caused the incidents, has provided product samples for independent testing, and has proactively quarantined certain product lines. The other five dispensaries and the cultivation facility in Ohio remain operational; Vext is cooperating with the DCC and will publish results as they become available. » Mere på de.investing.com
Vext Science increases margins and EBITDA in Q2 2026 despite revenue decline

Vext Science reported Q2 2026 revenue of $12.1 million (‑10% year on year), with a significantly higher gross margin of 55% and adjusted EBITDA of $3.4 million. Net loss fell to $0.3 million and gross profit rose to $6.7 million, supported by a stronger retail mix and better harvest yields in Ohio. The company is reducing cultivation in Arizona in favor of purchases and continues to focus on growth in Ohio, debt reduction and inventory conversion. The stock reacted positively, rising to $0.28; analysts expect profitability for the year. » Mere på de.investing.com
Vext Science reports Q3 revenue jump of 41% to 12.7 million USD

Vext Science increased revenue in the third quarter of 2025 by 41% to 12.7 million USD and recorded adjusted EBITDA of 2.1 million USD (margin 16.7%). The growth is attributed to expansions in Ohio and operational efficiency improvements in Arizona; the company plans eight dispensing locations in Ohio by 2026. Operating cash flow was 1.26 million USD, cash on hand stood at 3.7 million USD, and the stock rose 6.25% after the results. Vext Science expects improvements in revenue, adjusted EBITDA and cash flow for Q4, but sees risks from market saturation in Arizona and cross-regional price pressure. » Mere på de.investing.com

Virksomhedstal

I det seneste kvartal havde Vext Science en omsætning på 12,93 mio. € og et nettoresultat på -4,24 mio. €

(EUR)	september 2026	YoY
Omsætning	12,93 mio.	19,78 %
Bruttofortjeneste	-1,56 mio.	145,99 %
Nettoresultat	-4,24 mio.	89,31 %
EBITDA	-1,94 mio.	221,70 %

Fundamentale data

Nøgletal	Værdi
Markedsværdi	34,65 mio. €
Antal aktier	247,71 mio.
Højeste/laveste i 52 uger	0,26 € - 0,0897 €
Udbytte	Nej
Beta	0,80
P/E (PE Ratio)	-1,90
PEG (PEG Ratio)	0,29
K/I (PB Ratio)	0,79
P/S (PS Ratio)	0,74

Virksomhedsprofil

Vext Science, Inc. driver via sine datterselskaber virksomhed inden for integreret agroteknologi, tjenesteydelser og ejendomsforvaltning i cannabisbranchen i USA. Virksomheden er involveret i dyrkning, ekstraktion, fremstilling og salg af THC- og CBD-patroner, koncentrater og spiselige produkter. Den driver også detailaktiviteter med udsalgssteder for cannabis samt engroshandel med THC-cannabisprodukter og CBD-produkter af hamp under mærkerne Vapen og Pure Touch Botanicals. Derudover tilbyder virksomheden Vapen clear infused-produkter, THC-chokoladebarer, THC-sirup, THC-snacks, slik og gummivarer under mærket Vapen Kitchens. Virksomheden var tidligere kendt som Vapen MJ Ventures Corporation og ændrede navn til Vext Science, Inc. i november 2019. Vext Science, Inc. blev stiftet i 2015 og har hovedkontor i Phoenix, Arizona.